Andrew Hore

Andrew Hore is the publisher of AIM Journal, which is an online monthly publication covering the Alternative Investment Market.

Why companies left AIM in March 2023

New AIM admission: Ocean Harvest Technology

Likewise adds to market share

AIM movers: United Oil & Gas production increase and Light Science Technologies placing

Franchise Brands secures largest ever acquisition

New AIM admission: Onward Opportunities

AIM movers: Record order for Saietta and Tungsten West cuts costs

North America propels Gaming Realms

Burford Capital wins major case

Aquis weekly movers: Good Energy returns to profit

AIM weekly movers: ECSC takeover

AIM movers: Jersey Oil & Gas bounce back and Shearwater expectations slashed

AIM movers: Inland Homes subscription and ex-dividends

AIM movers: KCR Residential REIT discount and new low for Versarien

S&U improves lending quality

AIM movers: Unbound offer and SkinBioTherapeutics cash outflow

Marwyn Acquisition Company II appoints former Curtis Banks boss

Lettings offset sales decline at Belvoir

AIM movers: Verici Dx continues recovery and Scotgold Resources low ore grades

New Aquis admission: Essentially Group

Aquis weekly movers: Marula Mining appoints AIM float advisers

AIM weekly movers: Verici Dx reassures market

AIM movers: Blackbird recovers after director buying and Phoenix Copper bond issue

AIM movers: Zinnwald Lithium premium subscription and ex-dividends

AIM movers: Pathfinder Minerals finalises disposal and Anpario profit slump

AIM Movers: Manx Financial dividend hike and Eqtec falls below placing price

AIM movers: Third Xeros Technology licence and discounted Agriterra placing

New Aquis admission: Agglomeration plans for MBH Corporation

Aquis weekly movers: NFT Investments overhang sold

Tip update: Cordel’s Amtrak contract

Xpeng – the Tesla rival whose shares have rallied 315% in two months

23/11/2020

‘End of Austerity’ promise hashed out during PMQs

10/10/2018

Brexit: 5,000 City jobs could leave UK

10/10/2018

Advanced Oncotherapy shares soar after cancer treatment milestone

10/10/2018

Two reasons Travelodge backers can expect sleepless nights

24/07/2020